Table 2 CPET data in ME/CFS patients with a normal HR/BP response (group 1), ME/CFS patients with POTS (group 2), and ME/CFS patients with dOH (group 3), all with a significant CBF decrease as measured during HUT
CPET data | Group 1 NormHRBP (n = 105) | Group 2 POTS (n = 39) | Group 3 dOH (n = 27) | Ordinary one-way ANOVA with post hoc Tukey’s test |
|---|---|---|---|---|
HR rest (bpm) | 86 (14) | 86 (12) | 86 (15) | F (2, 168) = 0.02; p = 0.98 |
HR peak (bpm) | 147 (23) | 146 (19) | 146 (25) | F (2, 168) = 0.03; p = 0.97 |
SBP rest (mmHg) | 125 (16) | 120 (14) | 128 (15) | F (2, 168) = 1.25; p = 0.29 |
DBP rest (mmHg) | 84 (10) | 81 (11) | 83 (12) | F (2, 168) = 0.67; p = 0.52 |
SBP peak (mmHg) | 165 (26) | 158 (26) | 161 (26) | F (2, 168) = 0.79; p = 0.46 |
DBP peak (mmHg) | 99 (13) | 92 (13) | 96 (12) | F (2, 168) = 2.36; p = 0.10 |
VT VO2 (ml/min/kg) | 12 (4) | 11 (3) | 12 (4) | F (2, 168) = 1.28; p = 0.28 |
Peak VO2 (ml/min/kg) | 21 (7) | 19 (5) | 21 (7) | F (2, 168) = 0.80; p = 0.45 |
%VT VO2 | 41 (11) | 36 (11) | 41 (12) | F (2, 168) = 2.81; p = 0.06 |
%peak VO2 | 70 (21) | 62 (16) | 71 (21) | F (2, 168) = 2.59; p = 0.08 |
RER | 1.06 (0.12) | 1.11 (0.12) | 1.09 (0.12) | F (2, 168) = 2.12; p = 0.12 |